Comments
Dr Reddy’s Laboratories has initiated a voluntarily recall of over half-a-million bottles of Famotidine tablets from the US market as the drug failed impurities or degradation specifications.
According to a USFDA notification, the recall is being made under ’Class-III’ classification, which is described as "a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences''.
“Failed impurities/degradation specifications: Famotodine has an out of specification result for an individual related substance observed during routine stability testing of a batch for related substances — impurity 8 at 24 month stability interval,” the notification said on the reasons for recall.
As many as 5,69,376 bottles of Famotidine tablets, 10 mg belonging to multiple lots packaged in 30-count, are being recalled nationwide. The drug is an over-the-counter (OTC) product used to treat and prevent ulcers in stomach and intestines.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.